Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
- PMID: 33005157
- PMCID: PMC7479242
- DOI: 10.3389/fpsyt.2020.00859
Is the Adolescent Brain at Greater Vulnerability to the Effects of Cannabis? A Narrative Review of the Evidence
Abstract
Cannabis use during the critical neurodevelopmental period of adolescence, may lead to brain structural, functional, and histological alterations that may underpin some of the longer-term behavioral and psychological harms associated with it. The endocannabinoid system performs a key regulatory and homeostatic role, that undergoes developmental changes during adolescence making it potentially more susceptible to the effects of exposure to cannabis during adolescence. Here, we synthesize evidence from human studies of adolescent cannabis users showing alterations in cognitive performance as well as in brain structure and function with relevant preclinical evidence to summarize the current state of knowledge. We also focus on the limited evidence that speaks to the hypothesis that cannabis use during adolescence, may pose a greater risk than use during adulthood, identify gaps in current evidence and suggest directions for new research. Existing literature is consistent with the association of cannabis use during adolescence and neurological changes. Adolescence cannabis users show altered functional connectivity within known functional circuits, that may underlie inefficient recruitment of brain regions, as largely increased functional activation has been observed compared to controls. This disruption in some cases may contribute to the development of adverse mental health conditions; increasing the chances or accelerating the onset, of their development. Preclinical evidence, further supports disruption from cannabis use being specific to the developmental period. Future studies are required to better investigate adolescent cannabis use with more accuracy using better defined groups or longitudinal studies and examine the permanency of these changes following caseation of use. Furthermore, research is required to identify heritable risk factors to cannabis use. There is a need for caution when considering the therapeutic potential of cannabis for adolescence and particularly in public discourse leading to potential trivialization of possible harm from cannabis use in adolescence. Current evidence indicates that adolescence is a sensitive period during which cannabis use may result in adverse neurocognitive effects that appear to show a level of permanency into adulthood.
Keywords: adolescence; cannabis; marijuana; neurodevelopment; neurofuctioning.
Copyright © 2020 Blest-Hopley, Colizzi, Giampietro and Bhattacharyya.
Similar articles
-
Systematic review of structural and functional neuroimaging studies of cannabis use in adolescence and emerging adulthood: evidence from 90 studies and 9441 participants.Neuropsychopharmacology. 2022 Apr;47(5):1000-1028. doi: 10.1038/s41386-021-01226-9. Epub 2021 Nov 27. Neuropsychopharmacology. 2022. PMID: 34839363 Free PMC article.
-
Evidence for the Risks and Consequences of Adolescent Cannabis Exposure.J Am Acad Child Adolesc Psychiatry. 2017 Mar;56(3):214-225. doi: 10.1016/j.jaac.2016.12.014. Epub 2016 Dec 29. J Am Acad Child Adolesc Psychiatry. 2017. PMID: 28219487 Review.
-
Cannabis and adolescent brain development.Pharmacol Ther. 2015 Apr;148:1-16. doi: 10.1016/j.pharmthera.2014.11.009. Epub 2014 Nov 20. Pharmacol Ther. 2015. PMID: 25460036 Review.
-
Long lasting consequences of cannabis exposure in adolescence.Mol Cell Endocrinol. 2008 Apr 16;286(1-2 Suppl 1):S108-13. doi: 10.1016/j.mce.2008.02.003. Epub 2008 Feb 13. Mol Cell Endocrinol. 2008. PMID: 18358595 Review.
-
Disentangling the lasting effects of adolescent cannabinoid exposure.Prog Neuropsychopharmacol Biol Psychiatry. 2021 Jan 10;104:110067. doi: 10.1016/j.pnpbp.2020.110067. Epub 2020 Aug 11. Prog Neuropsychopharmacol Biol Psychiatry. 2021. PMID: 32791165 Review.
Cited by
-
Efficacy of cannabinoids in neurodevelopmental and neuropsychiatric disorders among children and adolescents: a systematic review.Eur Child Adolesc Psychiatry. 2024 Feb;33(2):505-526. doi: 10.1007/s00787-023-02169-w. Epub 2023 Mar 3. Eur Child Adolesc Psychiatry. 2024. PMID: 36864363 Free PMC article.
-
Cannabis use and episodic memory performance among adolescents: Moderating effects of depression symptoms and sex.J Int Neuropsychol Soc. 2023 Oct;29(8):715-723. doi: 10.1017/S135561772300005X. Epub 2023 Feb 13. J Int Neuropsychol Soc. 2023. PMID: 36775907 Free PMC article.
-
An Individuality of Response to Cannabinoids: Challenges in Safety and Efficacy of Cannabis Products.Molecules. 2023 Mar 20;28(6):2791. doi: 10.3390/molecules28062791. Molecules. 2023. PMID: 36985763 Free PMC article. Review.
-
Art therapy's engagement of brain networks for enduring recovery from addiction.Front Psychiatry. 2025 Jan 6;15:1458063. doi: 10.3389/fpsyt.2024.1458063. eCollection 2024. Front Psychiatry. 2025. PMID: 39834572 Free PMC article.
-
Trends in Marijuana Use among Adolescents in the United States.Pediatr Rep. 2024 Oct 15;16(4):872-879. doi: 10.3390/pediatric16040074. Pediatr Rep. 2024. PMID: 39449401 Free PMC article.
References
-
- Kann L, Kinchen S, Shanklin SL, Flint KH, Kawkins J, Harris WA, et al. Youth risk behavior surveillance–United States, 2013. MMWR Suppl (2014) 63(4):1–168. - PubMed
Publication types
Grants and funding
LinkOut - more resources
Full Text Sources